Petition to Ban Power Morcellator Surgery Now Has 62,800 Supporters, Bernstein Liebhard LLP Reports - San Diego, California News Station - KFMB Channel 8 - cbs8.com

Petition to Ban Power Morcellator Surgery Now Has 62,800 Supporters, Bernstein Liebhard LLP Reports

Posted:

This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.

SOURCE:

The Firm is evaluating power morcellator lawsuits on behalf of women who allegedly experienced the spread of uterine sarcoma and other gynecological cancers after undergoing a procedure aided by the device.

New York, NY (PRWEB) August 15, 2014

More than 62,800 signatures are now included on a petition created by a Boston couple campaigning to end power morcellator (http://www.gynecaremorcellatorlawsuit.com/ ) surgery in the U.S., Bernstein Liebhard LLP reports.

As of August 15th, the Change.org petition had 62,927 supporters who similarly seek to ban use of the devices in laparoscopic hysterectomy and fibroid removal procedures. The campaign was spearheaded by the husband of a woman who was diagnosed with uterine leiomyosarcoma, a life-threatening form of uterine cancer, after having fibroids removed in October 2013. Since then, concerns surrounding the possible risk for uterine morcellation procedures to promote the spread of uterine cancer cells throughout the peritoneal cavity have continued to gain momentum in the U.S.

We are pleased that more signatures have been added to this petition, as our Firm continues to hear from women whose uterine sarcoma and other cancers allegedly spread after power morcellator surgeries, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is actively investigating power morcellator lawsuits on behalf of women who may have received life-threatening cancer diagnoses after undergoing a uterine morcellation procedure.

Morcellator Lawsuits

The possible risks surrounding uterine morcellation have continued to gain media attention over the past several months, especially after the U.S. Food and Drug Administration (FDA) issued a public health alert in April that warned of the association between power morcellators and the spread of uterine sarcoma and other cancers. Among other things, the FDA alert estimated that 1 in every 350 women having fibroids removed may have undetected uterine sarcoma or another cancer prior to surgery, which may not be discovered until after fibroids are removed and biopsied.

Most recently, a study published in the Journal of the American Medical Association found that 1 in 368 women undergoing power morcellator surgeries may have undiagnosed uterine cancers. The research, which was released on July 22nd, 2014, also showed a higher likelihood of undetected cancer in women older than 65, and found that 32 percent of morcellation patients with the undiagnosed disease were younger than 50.*

On July 30th, Johnson & Johnson announced that it would be removing all power morcellators marketed by its subsidiary, Ethicon, Inc. from the market following its previous decision to cease sales of the devices. A notice posted on the companys website indicated that its Gynecare Morcellex, Gynecare X-Tract and Morcellex Sigma morcellator systems would be withdrawn due to uncertain risks associated with their use.**

Women who may have been diagnosed with uterine cancer after power morcellator surgery may be eligible to file a lawsuit seeking compensation for damages allegedly caused by the device. To learn more about the possible risk between uterine morcellation and uterine sarcoma, please visit Bernstein Liebhard LLPs website. To obtain a free legal review, please call 800-511-5092.

*jama.jamanetwork.com/article.aspx?articleid=1890400, JAMA, July 22, 2014
**ethicon.com/sites/default/files/managed-documents/Ethicon%20Morcellation%20Devices%20Customer%20Letter%20Final.pdf, Ethicon, Inc., July 30, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.gynecaremorcellatorlawsuit.com/
https://plus.google.com/115936073311125306742?rel=author

For the original version on PRWeb visit: http://www.prweb.com/releases/power-morcellator-lawsuit/uterine-sarcoma/prweb12099253.htm

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and Midwest Television, Inc. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.